11
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Biochemical Screening of Intellectually Disabled Patients: A Stepping Stone to Initiate a Newborn Screening Program in Pakistan

      Frontiers in Neurology
      Frontiers Media S.A.
      inborn errors of metabolism (iems), intellectual disability, newborn screening (nbs), evidence based medicine (ebm), homocystinuria, pakistan

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Inborn errors of metabolism (IEMs) are rare group of genetic disorders comprising of more than 1,000 different types. Around 200 of IEMs are potentially treatable through diet, pharmacological and other therapies, if diagnosed earlier in life. IEMs can be diagnosed early through newborn screening (NBS) programs, which are in place in most of the developed countries. However, establishing a NBS in a developing country is a challenging task due to scarcity of disease related data, large population size, poor economy, and burden of other common disorders. Since, not enough data is available for the prevalence of IEMs in Pakistan; therefore, in this study, we set out to find the prevalence of various treatable IEMs in a cohort of intellectually disabled patients suspected for IEMs, which will help us to initiate a NBS program for the most frequent IEMs in Pakistan. Therefore, a total of 429 intellectually disabled (IQ <70) patient samples were collected from Pakistan. A subset of 113 patient samples was selected based on the clinical information for the detailed biochemical screening. Advance analytical techniques like, Amino Acid Analyzer, GC-MS, UHPLC-MS, and MS/MS were used to screen for different treatable IEMs like aminoacidopathies, fatty acid β-oxidation disorders and mucopolysaccharidoses (MPS) etc. A total of 14 patients were diagnosed with an IEM i.e., 9 with homocystinuria, 2 with MPS, 2 with Guanidinoacetate methyltransferase (GAMT) deficiency and 1 with sitosterolemia. These IEMs are found frequent in the collected patient samples from Pakistan. Thus, present study can help to take an initiative step to start a NBS program in Pakistan, especially for the homocystinuria having highest incidence among aminoacidopathies in the studied patients, and which is amenable to treatment. This endeavor will pave the way for a healthier life of affected patients and will lessen the burden on their families and society.

          Related collections

          Most cited references33

          • Record: found
          • Abstract: found
          • Article: not found

          A proposed nosology of inborn errors of metabolism

          Purpose We propose a nosology for inborn errors of metabolism that builds on their recent redefinition. Methods We established a strict definition of criteria in order to develop a self-consistent schema for inclusion of a disorder into the nosology. Results We identified 1,015 well-characterized inborn errors of metabolism described in the literature. In addition, there are 111 less well-characterized conditions that may be inborn errors but do not meet strict criteria for inclusion in the current nosology. Conclusion We provide a master list of all currently recognized inborn errors of metabolism grouped according to their pathophysiological basis, with the hope of setting a standard against which new errors should be defined, as well as to promote awareness and foster collaboration in the area. With the rapid advances in the field of genetics in recent years, it is likely that this nosology will need to be updated in the near future, a process that will benefit from broader input and collaboration of experts in the field in order to improve future versions of the proposed classification.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            A targeted metabolomics approach for clinical diagnosis of inborn errors of metabolism

              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Expanded Newborn Screening for Inborn Errors of Metabolism and Genetic Characteristics in a Chinese Population

              The incidence of inborn errors of metabolisms (IEMs) varies dramatically in different countries and regions. Expanded newborn screening for IEMs by tandem mass spectrometry (MS/MS) is an efficient approach for early diagnosis and presymptomatic treatment to prevent severe permanent sequelae and death. To determine the characteristics of IEMs and IEMs-associated mutations in newborns in Jining area, China, 48,297 healthy neonates were recruited for expanded newborn screening by MS/MS. The incidence of IEMs was 1/1178 in Jining, while methylmalonic acidemia, phenylketonuria, and primary carnitine deficiency ranked the top 3 of all detected IEMs. Thirty mutations in nine IEMs-associated genes were identified in 28 confirmed cases. As 19 cases with the mutations in phenylalanine hydroxylase (PAH), solute carrier family 22 member 5 (SLC22A5), and methylmalonic aciduria (cobalamin deficiency) cblC type with homocystinuria (MMACHC) genes, respectively, it suggested that mutations in the PAH, SLC22A5, and MMACHC genes are the predominant causes of IEMs, leading to the high incidence of phenylketonuria, primary carnitine deficiency, and methylmalonic acidemia, respectively. Our work indicated that the overall incidence of IEMs is high and the mutations in PAH, SLC22A5, and MMACHC genes are the leading causes of IEMs in Jining area. Therefore, it is critical to increase the coverage of expanded newborn screening by MS/MS and prenatal genetic consulting in Jining area.
                Bookmark

                Author and article information

                Contributors
                Journal
                Front Neurol
                Front Neurol
                Front. Neurol.
                Frontiers in Neurology
                Frontiers Media S.A.
                1664-2295
                17 July 2019
                2019
                : 10
                : 762
                Affiliations
                [1] 1Health Biotechnology Division, National Institute for Biotechnology and Genetic Engineering (NIBGE) , Faisalabad, Pakistan
                [2] 2Pakistan Institute of Engineering and Applied Sciences , Islamabad, Pakistan
                [3] 3Department of Pediatrics, DHQ and Allied Hospitals, Faisalabad Medical University (FMU/PMC) , Faisalabad, Pakistan
                [4] 4Laboratory Genetic Metabolic Diseases, Department of Clinical Chemistry, Amsterdam University Medical Centers, University of Amsterdam , Amsterdam, Netherlands
                [5] 5Departments of Pediatrics and Clinical Genetics, Emma Children's Hospital, Amsterdam University Medical Centers, University of Amsterdam , Amsterdam, Netherlands
                Author notes

                Edited by: Austen J. Milnerwood, Montreal Neurological Institute and Hospital, McGill University, Canada

                Reviewed by: Liena Elbaghir Omer Elsayed, University of Khartoum, Sudan; Luca Marsili, University of Cincinnati, United States

                *Correspondence: Clara D. M. van Karnebeek c.d.vankarnebeek@ 123456amsterdamumc.nl
                Fazli Rabbi Awan awan.fr@ 123456gmail.com

                This article was submitted to Neurogenetics, a section of the journal Frontiers in Neurology

                †These authors have contributed equally to this work

                Article
                10.3389/fneur.2019.00762
                6650569
                31379716
                91c17815-d469-4c7f-abe3-7595506ce8f1
                Copyright © 2019 Wasim, Khan, Ayesha, Goorden, Vaz, van Karnebeek and Awan.

                This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

                History
                : 22 February 2019
                : 01 July 2019
                Page count
                Figures: 0, Tables: 3, Equations: 0, References: 49, Pages: 7, Words: 5186
                Funding
                Funded by: International Center for Genetic Engineering and Biotechnology 10.13039/100007675
                Funded by: Higher Education Commission, Pakistan 10.13039/501100004681
                Categories
                Neurology
                Original Research

                Neurology
                inborn errors of metabolism (iems),intellectual disability,newborn screening (nbs),evidence based medicine (ebm),homocystinuria,pakistan

                Comments

                Comment on this article